Genenta Science S.p.A. – NASDAQ:GNTA

Add to watchlist

$3.4

-1.48

-30.33%

Market closed

Open in 1 day

+46.99%

month

+46.99%

quarter

-2.14%

year

Market Cap	91.83M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-0.95

Revenue	N/A
EBITDA	-11.53M
Income	-11.49M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Genenta Science S.p.A. (NASDAQ:GNTA): Profit margin
Mar 2023	0	-3.37K
Jun 2023	0	-6.69M
Sep 2023	0	-2.44K
Dec 2023	0	-4.78M

Genenta Science S.p.A. Financials Estimate

Q Y

Genenta Science S.p.A. (NASDAQ:GNTA): Analyst Estimates
2025	0	-22.05M
2026	0	-27.33M
2027	75.86M	7.66M	10.1%
2028	171.66M	38.12M	22.21%

Analysts Price target
Financials & Ratios estimates

Genenta Science S.p.A. (NASDAQ:GNTA): Debt to assets
Mar 2023	26726055	1.92M	7.19%
Jun 2023	26726055	1.92M	7.19%
Sep 2023	22347145	1.91M	8.57%
Dec 2023	22365569	1.91M	8.57%

Genenta Science S.p.A. (NASDAQ:GNTA): Cash Flow
Mar 2023	-3.79K	-5K	0
Jun 2023	-7.50M	-9.90M	0
Sep 2023	-1.81K	-2.44K	0
Dec 2023	-3.55M	-4.80M	520

Genenta Science S.p.A. alternative data

Genenta Science S.p.A.
Employees

Genenta Science S.p.A. (NASDAQ:GNTA): Employee count
Aug 2023	4
Sep 2023	4
Oct 2023	4
Nov 2023	4
Dec 2023	4
Jan 2024	4
Feb 2024	4
Mar 2024	4
Apr 2024	4
May 2024	14
Jun 2024	14
Jul 2024	14

Genenta Science S.p.A.
Hedge Funds Holdings Q1 2023

0.25% -0.02%

of GNTA is owned by hedge funds

1 -3

hedge funds hold GNTA stock

45K -4.05K

shares is hold by hedge funds

GNTA hedge funds holdings changes

Genenta Science S.p.A.
Latest News

Wednesday, 23 October 2024
07:00	Genenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”	globenewswire.com
Wednesday, 2 October 2024
06:30	Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer	globenewswire.com
Tuesday, 28 May 2024
06:10	7 Penny Biotech Stocks to Triple Your Investment	investorplace.com
Monday, 6 May 2024
06:25	Genenta Welcomes New Directors John L. Cantello, Lauren H.	globenewswire.com
Thursday, 8 February 2024
05:00	Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors	globenewswire.com
Wednesday, 6 September 2023
07:00	Genenta to Present at Upcoming Scientific and Investor Conferences	GlobeNewsWire
Wednesday, 5 October 2022
08:05	Genenta to Present at Upcoming Scientific and Investor Conferences	GlobeNewsWire
Wednesday, 7 September 2022
07:00	Genenta to Present at Upcoming Investor Conferences	GlobeNewsWire
Friday, 13 May 2022
07:30	Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA	GlobeNewsWire
Thursday, 24 February 2022
07:30	Genenta to Participate at Upcoming Investor Conferences	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Genenta Science S.p.A. stock today?

One share of Genenta Science S.p.A. stock can currently be purchased for approximately $3.4.
When is Genenta Science S.p.A.'s next earnings date?

Unfortunately, Genenta Science S.p.A.'s (GNTA) next earnings date is currently unknown.
Does Genenta Science S.p.A. pay dividends?

No, Genenta Science S.p.A. does not pay dividends.
How much money does Genenta Science S.p.A. make?

Genenta Science S.p.A. has a market capitalization of 91.83M.
What is Genenta Science S.p.A.'s stock symbol?

Genenta Science S.p.A. is traded on the NASDAQ under the ticker symbol "GNTA".
What is Genenta Science S.p.A.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Genenta Science S.p.A.?

Shares of Genenta Science S.p.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Genenta Science S.p.A. have?

As Jul 2024, Genenta Science S.p.A. employs 14 workers, which is 250% more then previous quarter.
When Genenta Science S.p.A. went public?

Genenta Science S.p.A. is publicly traded company for more then 3 years since IPO on 15 Dec 2021.
What is Genenta Science S.p.A.'s official website?

The official website for Genenta Science S.p.A. is genenta.com.
Where are Genenta Science S.p.A.'s headquarters?

Genenta Science S.p.A. is headquartered at Via Olgettina No. 58, Milan, MI.
How can i contact Genenta Science S.p.A.?

Genenta Science S.p.A.'s mailing address is Via Olgettina No. 58, Milan, MI.

Genenta Science S.p.A.

genenta.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Via Olgettina No. 58
Milan, MI 20132

CIK: 0001838716
ISIN: US36870W1009
CUSIP: 36870W100